Cellink AB (publ)

BICO Group AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. The company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. It also offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It offers its products through online. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.